TF Market Research



Title:

BILIM PHARMACEUTICALS-COMPANY REPORT

Price:$1,120.00
Publication Date:Oct 17, 2007
Source:LIFE SCIENCE ANALYTICS
Author:HARINATHA, G.
Brief Excerpt:...Bilim Pharmaceuticals is one of the leading generic drug s manufacturing company in Turkey and is a part of the Bilfar Holding, which also includes Kopas Cosm etics. The company was founded in #### with a mission to protect human life by enabling better treatment of the diseases and enhanc e the quality of life. Its Vision is to further expand its domestic and international market share; to strengthen its global presence in the pharmaceutical market and to maximize value for its custom ers, workers and owners. Bilim's Research & Development is dedicated to perform all formulation development tasks and projects with the most up-to- date regulatory and scientific approaches. It is highly committed to enhance products as well as applying and developing improved techniques. The company's export department operates under Business Development which is divided into two groups Licensing-In and Licensing-Out. The company offers a wide range of products namely Systemic Anti Infectives,...
Length:28 Pages
Company:BILIM PHARMACEUTICALS INC
Geographic Regions:ASIAN CONTINENT, MIDDLE EAST, TURKEY
Format:Adobe Acrobat Adobe Acrobat

Sections
TitleStarting PageNumber of Pages
Company Information11
Bilim Pharmaceuticals [NonUS -- Symbol : Private]11
Formation Date: 195311
Business Summary11
Product Glance31
Diseasehub Classification31
Product Summary41
Condition Treated43
Description73
Therapeutic71
Current Trial76
Trial Details71
Last Updated71
4. Ventosal (salbutamol)81
5. Zespira (montelukast)81
Therapeutic91
9. Asist (acetylcysteine)91
Trial Details96
Last Updated92
12. Klamoks (amoxicillin trihydrate and potasium clavunate)101
Description113
Therapeutic111
Drug Class114
Last Updated122
Therapeutic133
Current Trial144
Last Updated151
30. Claricide (clarithromycin)151
31. Klindan (clindamycin phosphate)151
33. Travazol (diflucortolone valerate and isoconazole nitrate)161
Description161
34. Efedrin Arsan (ephedrine hydrochloride)161
Trial Details1611
37. Gentagut (gentamycin sulphate)171
Therapeutic173
Drug Class173
40. Spazmotek (hyoscine-N-butylbromide)181
Description181
Last Updated181
Current Trial192
44. Zeloxim (meloxicam) Fort Tablets191
48. Aprol (naproxen sodium)201
Description201
Last Updated208
49. Flaton201
51. Volpan (paracetamol)211
Therapeutic212
52. A-Ferin (paracetamol, codeine phosphate and chlorpheniramine maleate)211
Description223
Current Trial225
58. Pencain-K231
62. Gayaben241
65. Glifix (pioglitazone)251
66. Metsil (simethicone)251
Therapeutic263
Drug Class262
69. Combicid (ampicillin sodium and sulbactam sodium)261
Description262
73. Tobrased (tobramycin)271
Current Trial281
Trial Details281
Date281
Tables
TitleStarting PageNumber of Pages
of Contents21

Enter the keyword(s) which you would like to search for within this document and click "Search"

 
Purchase Report
Price: $1,120.00

Looking For Something Else?





TF Market Research

TF Market Research® reports contain in-depth primary research and statistics, market trends, forecasts, segment analysis and much more from over 100 top consulting, market research and business publishing sources. The service is updated daily.

  about us | contact us | public company index | private company index | pcan | widget | your privacy rights | terms & conditions  

Copyright © 2008 Alacra, Inc., 100 Broadway, Suite 1100, New York, NY 10005. All rights reserved.
Reproduction in whole or in part in any form or medium without express written permission is prohibited.